One week before her 38th birthday, Vanessa was diagnosed with a pre-invasive form of cervical cancer with a strong potential to develop and spread if not treated.
The FCS 2024 Annual Report has received an Award of Distinction in The 31st Annual Communicator Awards of the Academy of Interactive & Visual Arts (AIVA).
Thanks to rapid advancements in precision medicine, oncologists are able to personalize cancer treatment based on a patient’s unique molecular structure.
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience